Privia Health Group, Inc. (PRVA)
| Market Cap | 4.04B |
| Revenue (ttm) | 1.18B |
| Net Income (ttm) | -49.08M |
| Shares Out | 111.33M |
| EPS (ttm) | -1.99 |
| PE Ratio | n/a |
| Forward PE | 238.10 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,015,262 |
| Open | 36.33 |
| Previous Close | 36.63 |
| Day's Range | 35.64 - 37.36 |
| 52-Week Range | 17.99 - 41.85 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 37.09 (+2.1%) |
| Earnings Date | Aug 11, 2022 |
About PRVA
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that... [Read more...]
Financial Performance
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for PRVA stock is "Buy." The 12-month stock price forecast is 37.09, which is an increase of 2.09% from the latest price.
News
Privia Health (PRVA) Reports Q2 Loss, Tops Revenue Estimates
Privia Health (PRVA) delivered earnings and revenue surprises of -400% and 7.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Privia Health: The Self-Fashioned Uber Of Managed Care Is Extending Its Run
Privia Health easily beat second-quarter expectations for revenue and practice collections, leading the IPO stock to soar Thursday. The post Privia Health: The Self-Fashioned Uber Of Managed Care Is Ext...
Privia Health to Report Second Quarter 2022 Results on Thursday, August 11
ARLINGTON, Va., July 13, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its second quarter and six month periods ended J...
Privia Health (PRVA) Moves 7.4% Higher: Will This Strength Last?
Privia Health (PRVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the...
Stocks bounce but sell off for week; BYD, AstraZeneca, Privia Health In Focus | Stock Market Today
Here's what investors should be doing now. Get more IBD by subscribing to our channel: https://bit.ly/3OqppAs Visit our website: investors.com Like us on Facebook: https://www.facebook.com/investorsbusi...
Privia Receives HFMA's MAP Award for High Performance in Revenue Cycle for Seventh Straight Year
ARLINGTON, Va., June 27, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a re...
Privia Health (PRVA) Surges 8.1%: Is This an Indication of Further Gains?
Privia Health (PRVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the...
Privia Health to Participate in Upcoming Investor Conferences
ARLINGTON, Va., June 01, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), today announced that its management team plans to participate in a "fireside chat" Q&A session at the followin...
Privia Health (PRVA) Tops Q1 Earnings and Revenue Estimates
Privia Health (PRVA) delivered earnings and revenue surprises of 500% and 5.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Privia Health Reports First Quarter 2022 Financial Results
ARLINGTON, Va., May 12, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2022.
Earnings Preview: Privia Health (PRVA) Q1 Earnings Expected to Decline
Privia Health (PRVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Privia Health to Report First Quarter 2022 Results on Thursday, May 12
ARLINGTON, Va., April 11, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2022 before m...
Nancy Cocozza Joins Privia Health's Board of Directors
ARLINGTON, Va., March 31, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced the addition of Nancy Cocozza to its Board of Directors, increasing its Board to ten members. ...
Privia Health Reports Fourth Quarter 2021 Financial Results
ARLINGTON, Va., March 22, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2021.
Privia Health Leverages Amalgam Rx's EHR-Integrated Solutions to Personalize Care
WILMINGTON, Del.--(BUSINESS WIRE)-- #clinical--Amalgam Rx, Inc., a leader in connecting healthcare providers, payers, and life sciences companies through a SaaS-enabled digital marketplace and product p...
Privia Health to Participate in SVB Leerink Virtual Healthcare Conference
ARLINGTON, Va., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that the Company's management team will participate in a virtual fireside chat as part of the SVB Lee...
Javara Contributes to RSV Prevention Vaccine Trial in Collaboration with Privia Health and Moderna
WINSTON-SALEM, N.C., Feb. 14, 2022 /PRNewswire/ -- Javara, a leading Integrated Research Organization focused on delivering access to clinical trials at the point of care, today announced an opportunit...
Privia Health Partners with Surgery Partners; Enters Montana Market
ARLINGTON, Va. and BRENTWOOD, Tenn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) and Surgery Partners, Inc. (Nasdaq: SGRY) today announced a strategic agreement whereby Su...
Privia Health to Report Fourth Quarter 2021 Results on Friday, March 25
ARLINGTON, Va., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for the fourth quarter and full year ended December ...
Privia Health Launches Three New Accountable Care Organizations
ARLINGTON, Va., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), today announced it has launched three new Accountable Care Organizations (“ACOs”) in Maryland, Florida and Ten...
Jeff Sherman Joins Privia Health as Chief Financial Officer
ARLINGTON, Va., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that Jeffrey S. Sherman will join the company as Executive Vice President and Chief Financial Officer...
Privia Health Enters into Capitated Medicare Advantage Agreements
ARLINGTON, Va., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that two of its Accountable Care Organizations (“ACOs”) in Florida and the Mid-Atlantic region have e...
Privia Health to Participate in 40th Annual J.P. Morgan Healthcare Conference
ARLINGTON, Va., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it will participate in the 40th Annual J.P. Morgan Healthcare Conference. The Company's manageme...
Privia Health Announces Pricing of Secondary Offering
ARLINGTON, Va., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA, or “Privia Health” or the “Company”), a technology-driven, national physician enablement company that collabora...
Privia Health Announces Secondary Offering
ARLINGTON, Va., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA, or “Privia Health” or the “Company”), a technology-driven, national physician enablement company that collabora...